Mass Tort brief
Trial Pressure and Fraud Audits Shake MDL Dockets
From high-stakes medical device bellwethers to bot-riddled consumer settlements, courts tighten evidentiary standards and accelerate payout resolutions.
Mass Tort
Statutory pre-litigation reforms broke California's lemon-law filing boom — slashing automotive warranty dockets by nearly a third.
BackgroundCalifornia's Song-Beverly Consumer Warranty Act provides aggressive legal remedies and fee-shifting protections for purchasers of defective automobiles. Out-of-court dispute mechanisms were introduced to curb high-volume mass filings by specialized plaintiff warranty litigation firms.
- Vehicle-related warranty litigation fell by nearly a third from record highs, dropping to 5,400 cases in Los Angeles County Superior Court.
- Federal non-MDL vehicle product liability lawsuits across the state contracted to approximately 1,100 actions.
- Legal analysts attribute the decline to mandatory pre-litigation settlement procedures and altered billing strategies among high-volume firms.
Mass Tort
A $40M plaintiff verdict shattered Becton Dickinson's defense — and a second jury loss will force a global settlement across 4,000 catheter claims.
BackgroundImplantable port catheters allow healthcare providers to deliver chemotherapy infusions and intravenous medications directly into a patient's bloodstream over extended treatment regimens. Thousands of patients allege defective polyurethane formulations cause catheter fracturing, internal vascular damage, and severe systemic infections.
- Pending cases in MDL 3081 reached 4,140 claims consolidated before U.S. District Judge David G. Campbell in Phoenix, creating significant trial backlog.
- The trial in Lattanzio v. Becton Dickinson centers on severe bacterial infection risks tied to surface degradation, testing the defense's biofilm causation theory.
- Judge Campbell denied the defense's summary judgment motions, calendaring a fourth bellwether trial for December 1 to maintain relentless trial pressure.
Mass Tort
Pfizer is moving aggressively to cap liability — funneling 6,400 brain-tumor claims into a structured fund before bellwether trials begin.
BackgroundDepo-Provera is an injectable progestin contraceptive administered to millions of women worldwide since its initial approval in the 1990s. Scientific studies published this decade linked long-term use of the high-dose hormone shot to an elevated risk of intracranial meningiomas.
- Federal lawsuits alleging Pfizer failed to warn patients of meningioma risks grew to over 6,400 pending claims in MDL 3140, accelerating procedural deadlines.
- U.S. District Judge M. Casey Rodgers established settlement administration infrastructure, appointing Matt Garretson as Allocation Master to evaluate individual injury tiers.
- The proposed settlement program aims to resolve up to 80% of pending federal lawsuits before non-settling claims advance to individual trials.
Mass Tort
Uber is settling bellwethers on the courthouse steps — buying silence to protect its common-carrier liability from compounding before a jury.
BackgroundThe multidistrict litigation centralizes thousands of civil claims from passengers alleging Uber failed to implement adequate driver background checks and safety features. Previous bellwether trials established that Uber operates under common carrier legal duties and resulted in an $8.5M jury verdict.
- MDL 3084 before Senior U.S. District Judge Charles R. Breyer in San Francisco expanded to 4,916 pending passenger assault lawsuits.
- The settlement prevents another public damages verdict following an earlier trial that held the ride-hailing company liable as a common carrier.
- Attorneys for plaintiffs continue to challenge Uber's mandatory consumer arbitration agreements and background screening protocols across state courts.
Mass Tort
Mass Tort
Mass Tort
Unlock the full brief
Sign in to read every signal, takeaway, and source. Free account — Apple, Google, or email.
